Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of levofloxacin 750 mg taken once daily for 5 days to treat maxillary sinusitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Maxillary Sinusitis | Phase 3 | Status: COMPLETED